These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 18032310)
1. Morphine in children with cancer: impact of age, chemotherapy and other factors on protein binding. Mashayekhi SO; Hain RD; Buss DC; Routledge PA J Pain Palliat Care Pharmacother; 2007; 21(4):5-12. PubMed ID: 18032310 [TBL] [Abstract][Full Text] [Related]
2. Protein binding of indomethacin, methotrexate and morphine in patients with cancer. Raveendran R; Heybroek WM; Caulfield M; Abrams SM; Wrigley PF; Slevin M; Turner P Int J Clin Pharmacol Res; 1992; 12(3):117-22. PubMed ID: 1473877 [TBL] [Abstract][Full Text] [Related]
3. Impact of anti-cancer drugs and other determinants on serum protein binding of morphine 6-glucuronide. Mashayekhi SO; Ghandforoush-Sattari M; Buss DC; Routledge PA; Hain RD Daru; 2010; 18(2):107-13. PubMed ID: 22615603 [TBL] [Abstract][Full Text] [Related]
4. Characteristics of serum protein binding of felodipine. Valle M; Esteban M; Rodríguez-Sasiaín JM; Calvo R; Aguirre C Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):73-88. PubMed ID: 8948016 [TBL] [Abstract][Full Text] [Related]
5. Effects of protein binding on the in vitro activity of antitumour acridine derivatives and related anticancer drugs. Finlay GJ; Baguley BC Cancer Chemother Pharmacol; 2000; 45(5):417-22. PubMed ID: 10803926 [TBL] [Abstract][Full Text] [Related]
6. Determination of the serum protein binding of oxycodone and morphine using ultrafiltration. Leow KP; Wright AW; Cramond T; Smith MT Ther Drug Monit; 1993 Oct; 15(5):440-7. PubMed ID: 8249052 [TBL] [Abstract][Full Text] [Related]
7. Differences in the serum binding determinants of isradipine and darodipine--consequences for serum protein binding in various diseases. Pinquier JL; Urien S; Chaumet-Riffaud P; Tillement JP Br J Clin Pharmacol; 1989 Nov; 28(5):587-92. PubMed ID: 2531607 [TBL] [Abstract][Full Text] [Related]
8. Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer. Calvo R; Jiménez RM; Trocóniz IF; Suárez E; Gonzalo A; Lucero ML; Raczka E; Orjales A Cancer Chemother Pharmacol; 1998; 42(5):418-22. PubMed ID: 9771958 [TBL] [Abstract][Full Text] [Related]
9. Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure. Zini R; Morin D; Salvadori C; Tillement JP Br J Clin Pharmacol; 1990 Jan; 29(1):9-18. PubMed ID: 2297464 [TBL] [Abstract][Full Text] [Related]
10. Protein binding of piritramide: influence of various protein concentrations and the postoperative acute phase response. Wiesner G; Gruber M; Wild K; Hoerauf K; Taeger K Eur J Clin Pharmacol; 1999 Jan; 54(11):843-5. PubMed ID: 10027658 [TBL] [Abstract][Full Text] [Related]
11. Interaction between human serum albumin and alpha 1-acid glycoprotein in the binding of lidocaine to purified protein fractions and sera. Krauss E; Polnaszek CF; Scheeler DA; Halsall HB; Eckfeldt JH; Holtzman JL J Pharmacol Exp Ther; 1986 Dec; 239(3):754-9. PubMed ID: 3795040 [TBL] [Abstract][Full Text] [Related]
12. Determinants of the plasma protein binding of theophylline in health. Buss D; Leopold D; Smith AP; Routledge PA Br J Clin Pharmacol; 1983 Apr; 15(4):399-405. PubMed ID: 6849774 [TBL] [Abstract][Full Text] [Related]
13. Factors affecting serum protein binding of cocaine in humans. Parker RB; Williams CL; Laizure SC; Lima JJ J Pharmacol Exp Ther; 1995 Nov; 275(2):605-10. PubMed ID: 7473145 [TBL] [Abstract][Full Text] [Related]
14. Increase of plasma nonesterified fatty acid concentration and decrease of albumin binding affinity after intravenous injection of glycocholate-lecithin mixed micelles. Guentert TW; Frey BM; Luedin E; Heinzl S; Brodersen R J Lab Clin Med; 1990 Jul; 116(1):66-75. PubMed ID: 2376700 [TBL] [Abstract][Full Text] [Related]
15. Fentanyl and alfentanil plasma protein binding in preterm and term neonates. Wilson AS; Stiller RL; Davis PJ; Fedel G; Chakravorti S; Israel BA; McGowan FX Anesth Analg; 1997 Feb; 84(2):315-8. PubMed ID: 9024020 [TBL] [Abstract][Full Text] [Related]
16. The plasma protein binding of metoclopramide in health and renal disease. Webb D; Buss DC; Fifield R; Bateman DN; Routledge PA Br J Clin Pharmacol; 1986 Mar; 21(3):334-6. PubMed ID: 3964535 [TBL] [Abstract][Full Text] [Related]
17. Binding of bupivacaine to human serum proteins, isolated albumin and isolated alpha-1-acid glycoprotein. Differences between the two enantiomers are partly due to cooperativity. Mazoit JX; Cao LS; Samii K J Pharmacol Exp Ther; 1996 Jan; 276(1):109-15. PubMed ID: 8558418 [TBL] [Abstract][Full Text] [Related]
18. Altered serum protein binding of carbamazepine in disease states associated with an increased alpha 1-acid glycoprotein concentration. Baruzzi A; Contin M; Perucca E; Albani F; Riva R Eur J Clin Pharmacol; 1986; 31(1):85-9. PubMed ID: 3780833 [TBL] [Abstract][Full Text] [Related]
19. Role of alpha-1 acid glycoprotein, albumin, and nonesterified fatty acids in serum binding of apazone and warfarin. Urien S; Albengres E; Pinquier JL; Tillement JP Clin Pharmacol Ther; 1986 Jun; 39(6):683-9. PubMed ID: 3709033 [TBL] [Abstract][Full Text] [Related]
20. Opioid binding sites in human serum albumin. Zhou R; Perez-Aguilar JM; Meng Q; Saven JG; Liu R Anesth Analg; 2012 Jan; 114(1):122-8. PubMed ID: 22025496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]